Cumulatively, rare disorders and diseases are not so rare at all. There are approximately 300 million people living with a rare disease worldwide.
(Source: The Lancet Global Health)
Yet, there’s still a significant gap when it comes to clinical studies and research. This needs to change.
Our team believes those affected by rare conditions and diseases should not feel marginalised or neglected, which is why it’s our mission — indeed our passion — to offer drug development solutions in this area.
For nearly 25 years, our experts have dedicated their time to supporting the progression of life-saving treatment for rare diseases worldwide.
We’re more than just a CRO. At the heart of everything we do are the patients we aim to serve through clinical studies and research.
Our promise
We’re people-driven and patient-focused. TMC FIT is our promise to our clients and the patients they serve.
We achieve the perfect FIT by being:
- Flexible in our business model.
- Integrated in our personalised approach.
- Tailored in our ability to provide innovative and unique solutions.
Our focus areas
Our expert in-house team and global network of trusted, knowledgeable and highly skilled associates have a wealth of experience in a breadth of rare disease areas — each of them bringing at least 15 years’ worth of experience to every project.
Over our 25-year history, we’ve gained experience in these key specialisms:
- Oncology
- Respiratory diseases
- Neurological disorders
- Haematology
- Ophthalmological conditions
- Hepatology
- Nephrology diseases
- Neonatology
